Engineered immune cells take on tough lupus cases
Disease control
Recruiting now
This early-phase study tests an experimental treatment called QT-019B for people with refractory systemic lupus erythematosus (SLE) that hasn't responded to standard therapies. The treatment uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and p…
Phase: PHASE1 • Sponsor: Hangzhou Qihan Biotech Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC